Zynerba Pharmaceuticals Inc announces presentation of poster on Zygel at the 2022 Society of Biological Psychiatry Annual Meeting

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Inc said it presented a poster on the long-term safety and efficacy of its cannabidiol transdermal gel, Zygel, at the...

Related Keywords

Louisiana ,United States ,New Orleans ,Armando Anido ,Society Of Biological Psychiatry ,Zynerba Pharmaceuticals ,European Commission ,Biological Psychiatry ,Annual Meeting ,Long Term Safety ,Sustained Efficacy ,Transdermal Gel ,Fragilex Syndrome ,Fast Track ,